Register information Patent

DE file number : 60 2011 019 399.6 (Status: pending/in force, Query started: May 3, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 019 399.6
96EP file numberEAKZ11 74 9833.7
86WO file numberWAKZPCT/EP2011/064877
97EP publication numberEPN2611825
87WO publication numberWPN2012028602
54Designation/titleTIFESTPHASENSYNTHESE VON H(GLY2)GLP-2
51IPC main classICM
(ICMV)		 C07K 14/605 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07K 1/04 (2006.01)
22DE application dateDATAug 30, 2011
96EP application dateEATAug 30, 2011
86WO application dateWATAug 30, 2011
43Date of first publicationOTMar 8, 2012
Date of publication of grantPETSep 2, 2015
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
72InventorINWELLINGS, Don, Northwich Cheshire CW9 2AU, GB
74RepresentativeVTRMaiwald GmbH, 80335 München, DE
Address for service Maiwald GmbH, 80335 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
EP
10174559
Aug 30, 2010
Due dateFT
FG		Aug 31, 2025
Annual fee for the 15th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002611825
Searchable text: EP000002611825
Original document: EP000002611825B1
Searchable text: EP000002611825B1
Original document: WO002012028602
Searchable text: WO002012028602
43Date of first publicationEVTMar 8, 2012
Date of the first transfer into DPMAregisterEREGTAug 23, 2013
Date of the (most recent) update in DPMAregisterREGTJul 30, 2024
(Show all update days)(Hide all update days)
  • Jul 30, 2024
    • Due date: changed
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 08.03.2012: deleted
  • May 17, 2024; Oct 12, 2023; Sep 5, 2023; Jul 29, 2023; Oct 24, 2022; Aug 5, 2022; Jul 28, 2021; Jul 27, 2020; Aug 21, 2019; Aug 2, 2019; Apr 25, 2019; Mar 20, 2019; Feb 14, 2019; Jul 28, 2018; May 19, 2018; May 8, 2018; Aug 31, 2017; Jun 8, 2017; Sep 7, 2016; Aug 11, 2016; Dec 5, 2015; Oct 8, 2015; Sep 4, 2015; Sep 3, 2015
    • Historical data not available for this/these date(s)
  • Aug 23, 2013
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Mar 8, 2012  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Jul 10, 2013  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Aug 22, 2013 Aug 22, 2013 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Sep 2, 2015  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Oct 15, 2015 Oct 15, 2015 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jun 3, 2016 Sep 15, 2016 Details anzeigen
7 New applicant/owner details New applicant/owner details Mar 19, 2019 Apr 25, 2019 Details anzeigen
8 New applicant/owner details New applicant/owner details Sep 4, 2023 Oct 12, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTMar 8, 2012
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJul 10, 2013
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTAug 22, 2013
Issue numberHN34
YearPJ2013
Publication dateVTAug 22, 2013
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTSep 2, 2015
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTOct 15, 2015
Issue numberHN42
YearPJ2015
Publication dateVTOct 15, 2015
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJun 3, 2016
Issue numberHN37
YearPJ2016
Publication dateVTSep 15, 2016
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMar 19, 2019
Issue numberHN17
YearPJ2019
Publication dateVTApr 25, 2019
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHShire-NPS Pharmaceuticals, Inc. (n. d. Ges. d. Staates Delaware), 02421 Lexington, Mass., US
71/73Previous applicant/ownerINHFNPS Pharmaceuticals, Inc., Bedminster, N.J., US
View procedures New applicant/owner details (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTSep 4, 2023
Issue numberHN41
YearPJ2023
Publication dateVTOct 12, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
71/73Previous applicant/ownerINHFShire-NPS Pharmaceuticals, Inc. (n. d. Ges. d. Staates Delaware), 02421 Lexington, Mass., US
Date of update of the procedureREGTOct 12, 2023